Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA.
Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1134-46. doi: 10.1152/ajpheart.00887.2012. Epub 2013 Feb 15.
Myocardial depression is an important contributor to morbidity and mortality in septic patients. Nitric oxide (NO) plays an important role in the development of septic cardiomyopathy, but also has protective effects. Recent evidence has indicated that NO exerts many of its downstream effects on the cardiovascular system via protein S-nitrosylation, which is negatively regulated by S-nitrosoglutathione reductase (GSNOR), an enzyme promoting denitrosylation. We tested the hypothesis that reducing cardiomyocyte S-nitrosylation by increasing GSNOR activity can improve myocardial dysfunction during sepsis. Therefore, we generated mice with a cardiomyocyte-specific overexpression of GSNOR (GSNOR-CMTg mice) and subjected them to endotoxic shock. Measurements of cardiac function in vivo and ex vivo showed that GSNOR-CMTg mice had a significantly improved cardiac function after lipopolysaccharide challenge (LPS, 50 mg/kg) compared with wild-type (WT) mice. Cardiomyocytes isolated from septic GSNOR-CMTg mice showed a corresponding improvement in contractility compared with WT cells. However, systolic Ca(2+) release was similarly depressed in both genotypes after LPS, indicating that GSNOR-CMTg cardiomyocytes have increased Ca(2+) sensitivity during sepsis. Parameters of inflammation were equally increased in LPS-treated hearts of both genotypes, and no compensatory changes in NO synthase expression levels were found in GSNOR-overexpressing hearts before or after LPS challenge. GSNOR overexpression however significantly reduced total cardiac protein S-nitrosylation during sepsis. Taken together, our results indicate that increasing the denitrosylation capacity of cardiomyocytes protects against sepsis-induced myocardial depression. Our findings suggest that specifically reducing protein S-nitrosylation during sepsis improves cardiac function by increasing cardiac myofilament sensitivity to Ca(2+).
心肌抑制是脓毒症患者发病率和死亡率的重要因素。一氧化氮(NO)在脓毒性心肌病的发展中起重要作用,但也具有保护作用。最近的证据表明,NO 通过蛋白质 S-亚硝基化发挥其对心血管系统的许多下游作用,而 S-亚硝基化还原酶(GSNOR)负调节 S-亚硝基化还原酶,促进去亚硝基化。我们检验了这样一个假设,即通过增加 GSNOR 活性减少心肌细胞的 S-亚硝基化可以改善脓毒症期间的心肌功能障碍。因此,我们生成了心肌细胞特异性过表达 GSNOR 的小鼠(GSNOR-CMTg 小鼠),并对其进行内毒素休克处理。体内和离体心脏功能测量显示,与野生型(WT)小鼠相比,GSNOR-CMTg 小鼠在脂多糖(LPS,50mg/kg)挑战后心脏功能明显改善。与 WT 细胞相比,从脓毒症 GSNOR-CMTg 小鼠分离的心肌细胞收缩力也相应改善。然而,LPS 后两种基因型的收缩期 Ca2+释放均明显降低,表明 GSNOR-CMTg 心肌细胞在脓毒症期间 Ca2+敏感性增加。两种基因型 LPS 处理的心脏炎症参数均增加,并且在 LPS 挑战前后 GSNOR 过表达心脏中均未发现一氧化氮合酶表达水平的代偿性变化。然而,GSNOR 过表达在脓毒症期间显著降低了总心脏蛋白 S-亚硝基化。总之,我们的研究结果表明,增加心肌细胞的去亚硝基化能力可预防脓毒症引起的心肌抑制。我们的研究结果表明,在脓毒症期间特异性减少蛋白质 S-亚硝基化可通过增加心肌肌丝对 Ca2+的敏感性来改善心脏功能。